SQUAWK/NEWS
Menu
Live News EQUITY FLASH M impact

Aprea Therapeutics Accelerates APR-1051 Enrollment

Aprea accelerates APR-1051 clinical trial enrollment

APRE

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.